![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/48 | |
A61K 47/10 | |||
A61K 47/18 | |||
A61K 47/20 | |||
A61K 47/26 | |||
A61K 47/34 | |||
A61K 47/02 |
(11) | Patento numeris | 3432916 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17777119.3 |
Europos patento paraiškos padavimo data | 2017-09-13 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-01-30 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-14 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2017/051394 |
Data | 2017-09-13 |
(87) | Numeris | WO 2018/053021 |
Data | 2018-03-22 |
(30) | Numeris | Data | Šalis |
201662394009 P | 2016-09-13 | US |
(72) |
ABIAD, Maurice, US
DANI, Bhas, US
SHALAEV, Evgenyi, US
|
(73) |
Allergan, Inc.,
2525 Dupont Drive, Irvine, California 92612,
US
|
(54) | STABILIZED NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS |
STABILIZED NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS |